RESEARCH ARTICLE: Identifying the teaching content on substandard and falsified medical products in global pharmacy education as critical public health issue

Authors

  • Zuzana Kusynová International Pharmaceutical Federation (FIP) & Utrecht University, The Netherlands https://orcid.org/0000-0003-3875-7108
  • Mart Kicken International Pharmaceutical Federation (FIP) & Utrecht University, The Netherlands
  • Hendrika A. van den Ham Utrecht University, Utrecht, The Netherlands
  • Aukje K. Mantel-Teeuwisse Utrecht University, Utrecht, The Netherlands https://orcid.org/0000-0002-8782-0698

DOI:

https://doi.org/10.46542/pe.2021.211.504516

Keywords:

Pharmacy education, Pharmacy curriculum, Substandard and falsified (SF) medical products

Abstract

Aim: To gain insight into the education about substandard and falsified (SF) medical products.   

Method: A digital survey was sent to 173 different schools of pharmacy around the world.   

Results: The response rate was 32% (55 responses, 37 countries). Most schools taught about SF medical products as a stand-alone course or as part of another course or module (67%), whereas 33% did not teach about the subject. The main focus of teaching was on detection (21%) and prevention (21%) of SF medical products, while reporting was taught the least (12%), indicating a knowledge gap in that area. A key barrier to introducing a new course that could close the gaps was insufficient time in pharmacy curriculum (n=33; 60%), while availability of ready-to-adopt course materials was considered as a helpful enabler.   

Conclusion: These insights can improve the understanding on what is already being taught on SF medical products, where the gaps are and inform the curriculum needed globally.

Author Biographies

Zuzana Kusynová , International Pharmaceutical Federation (FIP) & Utrecht University, The Netherlands

Utrecht Centre for Pharmaceutical Policy and Regulation, Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences

Mart Kicken, International Pharmaceutical Federation (FIP) & Utrecht University, The Netherlands

Utrecht Centre for Pharmaceutical Policy and Regulation, Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences

Hendrika A. van den Ham, Utrecht University, Utrecht, The Netherlands

Utrecht Centre for Pharmaceutical Policy and Regulation, Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences

Aukje K. Mantel-Teeuwisse, Utrecht University, Utrecht, The Netherlands

Utrecht Centre for Pharmaceutical Policy and Regulation, Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences

References

Accreditation council for pharmacy education. (2015). Accreditation standards and key elements for the professional program in pharmacy leading to the doctor of pharmacy degree. Chicago

Aiyer, M., Hemmer, P., Meyer, L., Albritton, T. A., Levine, S., & Reddy, S. (2002). Evidence-based medicine in internal medicine clerkships: a national survey. Southern medical journal, 95(12), 1389–1395. United States. https://doi.org/10.1097/00007611-200295120-00007

Blanco, M. A., Capello, C. F., Dorsch, J. L., Perry, G., & Zanetti, M. L. (2014). A survey study of evidence-based medicine training in US and Canadian medical schools. Journal of the Medical Library Association : JMLA, 102(3), 160–168. Medical Library Association. https://doi.org/10.3163/1536-5050.102.3.005

Director General Seventieth World Health Assembly. (2017). A70/23 - Member State Mechanism on Substandard/Spurious/Falsely-labelled/Falsified/Counterfeit Medical Products. Retrieved from https://www.who.int/medicines/regulation/ssffc/mechanism/A70_23-en6-14.pdf?ua=1

Ferrario A, Wirtz VJ, Z. M. (2018). Education about substandard and falsified medicines: a review of Bachelor in Pharmacy curricula in six countries. Medicine Quality & Public Health Conference. Oxford

Ferrario, A., Orubu, E. S. F., Adeyeye, M. C., Zaman, M. H., & Wirtz, V. J. (2019). The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists. BMJ Global Health, 4(4), e001681. https://doi.org/10.1136/bmjgh-2019-001681

FIP (International Pharmaceutical Federation). (2018). Pharmacists in the supply chain: The role of the medicines expert in ensuring quality and availability. The Hague

FIP (International Pharmaceutical Federation). (2020). FIP pharmacy education in sub-Saharan Africa — The FIP-UNESCO UNITWIN Programme: A decade of education partnership across Africa

FIP (International Pharmaceutical Federation). (2021). Curriculum for pharmacy students on substandard and falsified medicines. The Hague. Retrieved from https://www.fip.org/file/4917

International Association of Medical Regulatory Authorities. (n.d.). What is a medical regulatory authority? Retrieved January 2, 2021, from https://www.iamra.com/What-is-a-Medical-Regulatory-Authority#:~:text=Medical Regulatory Authority%3F-,What is a medical regulatory authority%3F,profession of medicine%3B and%2For

Kheir, N., Zaidan, M., Younes, H., El Hajj, M., Wilbur, K., & Jewesson, P. J. (2008). Pharmacy education and practice in 13 Middle Eastern countries. American journal of pharmaceutical education, 72(6), 133. American Journal of Pharmaceutical Education. https://doi.org/10.5688/aj7206133

Meats, E., Heneghan, C., Crilly, M., & Glasziou, P. (2009). Evidence-based medicine teaching in UK medical schools. Medical teacher, 31(4), 332–337. England. https://doi.org/10.1080/01421590802572791

Medina, M. S., Plaza, C. M., Stowe, C. D., Robinson, E. T., DeLander, G., Beck, D. E., Melchert, R. B., et al. (2013). Center for the Advancement of Pharmacy Education 2013 educational outcomes. American journal of pharmaceutical education, 77(8), 162. American Journal of Pharmaceutical Education. https://doi.org/10.5688/ajpe778162

Ozawa, S., Evans, D. R., Bessias, S., Haynie, D. G., Yemeke, T. T., Laing, S. K., & Herrington, J. E. (2018). Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. JAMA Network Open, 1(4), e181662–e181662. https://doi.org/10.1001/jamanetworkopen.2018.1662

Pyzik, O. (2018). Global Pharmacy Education & UCL Fight the Fakes. Medicine Quality & Public Health Conference. Oxford.

World Bank. (2020). World Bank list of economies (June 2020). Retrieved from https://databank.worldbank.org/data/download/site-content/CLASS.xls

World Health Organization. (2017a). WHO Global Surveillance and Monitoring System for substandard and falsified medical products. Geneva.

World Health Organization. (2017b). Seventieth World Health Assembly. Retrieved from https://www.who.int/medicines/regulation/ssffc/A70_23-en1.pdf?ua=1

World Health Organization. (2019). Agreed list of prioritized activities to implement the workplan of the member state mechanism for the periode 2020-2021. Retrieved from https://www.who.int/medicines/regulation/ssffc/mechanism/A_MSM8_4-en-6-8.pdf?ua=1

World Health Organization. (2020). World Health Statistics 2020: : monitoring health for the SDGs, sustainable development goals. Retrieved from https://www.who.int/data/gho/publications/world-health-statistics

World Health Organization. (n.d.). Essential medicines and health products - WHO Member State Mechanism. Retrieved from https://www.who.int/medicines/regulation/ssffc/mechanism/en/

Published

10/09/2021

Issue

Section

Research Article